420 related articles for article (PubMed ID: 3865743)
1. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
Shima K; Tanaka A; Ejiri N; Maezawa H
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
[TBL] [Abstract][Full Text] [Related]
2. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
Bukowska H
Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
[TBL] [Abstract][Full Text] [Related]
3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
4. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
[TBL] [Abstract][Full Text] [Related]
5. Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients.
Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S; Saniabadi AR; Nakajima K
Horm Metab Res; 2004 May; 36(5):298-302. PubMed ID: 15156409
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
7. LDL molecular size as risk factor in coronary artery disease.
Kozma L; Fodor J; Chockalingam A; Sussex B
Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
[TBL] [Abstract][Full Text] [Related]
8. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
[TBL] [Abstract][Full Text] [Related]
9. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
10. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
Artery; 1983; 12(1):1-23. PubMed ID: 6431945
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid and lipoprotein concentration in coronary heart disease.
Luknárová O; Kusá O; Riecanský I; Zelenay J
Cor Vasa; 1985; 27(4):266-71. PubMed ID: 4053617
[TBL] [Abstract][Full Text] [Related]
13. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
14. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
15. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
Sasaki J; Koga S; Uzawa H; Arakawa K
Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
[TBL] [Abstract][Full Text] [Related]
19. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
20. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
Onat A
Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
